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Background and Aims: Helicobacter pylori are the most common gastrointestinal in-
fection worldwide. Determination of contributing factors for successful eradication of 
Helicobacter pylori is important for better infection control. Therefore, this study was 
conducted to investigate the association between serum vitamin D deficiency and He-
licobacter pylori eradication rate.
Materials and Methods: In this nested case control study in Loghman Hospital in Teh-
ran in 2018 and 2019, 200 consecutive patients with Helicobacter pylori infection using 
amoxicillin, pantoprazole, bismuth, and metronidazole for 4 weeks were enrolled. The 
serum vitamin D level was compared across the groups with successful (n=153) versus 
unsuccessful (n=47) eradication of infection. Finally, data analysis was performed us-
ing SPSS statistical software version 25 and the mean, standard deviation, frequency, 
percentage and statistical test of Chi-square were used to describe and analyze the 
data and the significance level in this study was less than 0.05. 
Results: The results of this study demonstrated that before-treatment vitamin D level 
was between 10 and 20 ng/dL in majority of unsuccessful cases (40.4%) and it was 
more than 30 ng/dL in majority of successful cases (83.7%) showing statistically signif-
icant difference (P < 0.001).
Conclusion: This study showed a significant association between vitamin D deficien-
cy and Helicobacter pylori eradication and low vitamin D level resulted in failure of 
treatment; Hence in unsuccessful cases, assessment of vitamin D level and possible 
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Helicobacter pylori (Hp) is a gram-negative, microaero-
philic, and spiral bacterium that colonizes the stomach of 
humans. The prevalence of this bacterium is very high, from 
25% in developed countries to 90% in developing countries 
[1, 2]. The bacterium causes some diseases involving the 
gastrointestinal tract, including chronic gastritis, peptic ul-
cer, mucosa-associated lymphoid tissue (MALT) lympho-
ma, and gastric cancer [3]. Concerning ulcers, 76%–95% 
of gastric ulcers and 90% of duodenal ulcers are associated 
with Hp infection [4]. Hp infection treatment and eradica-
tion is significantly effective in the treatment of gastric ul-
cer and gastric lymphoma, so successful eradication of this 
pathogen can prevent gastric cancer [5, 6]. According to 
previous studies, factors influencing the eradication failure 
of Hp include low drug compliance, antibiotic resistance, 
microbial virulence factors, genetic factors in the host, 
smoking, alcohol consumption, and diabetes [7-9]. Besides, 
it is clear that, like other infections, host immunity plays an 
essential role against Hp infection. Many of recent studies 
have shown that vitamin D, in addition to its known role 
in calcium and phosphorus metabolism, acts as an anti-in-
flammatory agent and immune system regulator. This vi-
tamin plays a role in reducing the risk of chronic diseases 
such as some common cancers, autoimmune, cardiovascu-
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patients in study have not taken vitamin D in the past year. 
This study was approved by the ethics committee of Shahid 
Beheshti University of Medical Sciences (IR.SBMU.MSP.
REC.1398.197). 
Data analysis method
Finally, data analysis was performed using SPSS ver. 25. 
The mean and standard deviations were used to describe 
quantitative variables and the number and percentage were 
used to describe qualitative variables. The inter-group com-
parison was carried out using chi-square test and P-value < 
0.05 was considered as the significance level.
RESULTS
In this study, 200 patients with Hp infection who underwent 
Hp eradication therapy using amoxicillin, metronidazole, 
bismuth, and pantoprazole for four weeks were divided 
into following groups based on the urea breath test: optimal 
therapeutic response (n=153 people) and treatment failure 
(n=47 people).
In the group with positive urea breath test, 18, 13, and 16 
people, and in the group with negative urea breath test, 
51, 64, and 38 people were in the <35, 35-55, and >55 age 
groups, respectively. There was no significant difference 
between the two groups in terms of age group distribution 
(P = 0.2).
There were 33 (2.70%) and 95 females (1.62%), respec-
tively, in the groups with and without treatment failure, and 
the rest were male. There was no significant difference be-
tween the two groups in terms of sex distribution (P = 0.4). 
Table 1 shows the distribution of the two groups with and 
without treatment failure based on body mass index (BMI). 
There was also no significant difference between the two 
groups in terms of this variable (P = 0.6).
lar, and infectious diseases. Infections of the urinary tract, 
respiratory tract and tuberculosis and deficiency of vitamin 
D can lead to an increase in immune system disorders and 
be risk factors for the development of infectious diseases, 
including urinary tract and respiratory infections and tu-
berculosis [10-14]. Laboratory studies have shown that vi-
tamin D binds to its receptor (vitamin D Receptor: VDR), 
activating a signal pathway that triggers several immune 
responses. This vitamin is involved in the regulation of the 
immune response in many infectious diseases by regulating 
the expression of a number of endogenous antimicrobial 
peptides [15-17]. Laboratory studies have also shown that 
vitamin D and its decomposition products have an antimi-
crobial effect, specifically against Hp bacterium, and play 
a role in homeostasis of gastric mucosa and protection of 
host against this pathogen. Also, VDR is up regulated in 
the gastric epithelium in the presence of Hp [18-20]. How-
ever, there are few clinical studies on the effect of vitamin 
D on Hp eradication treatment, some of which have been 
performed on specific populations such as the elderly or 
diabetic people, and the presence of intervening factors that 
are effective on the results is not fully known [21, 22]. Con-
sidering the high prevalence of Hp infection and the impor-
tance of its eradication, it is important to eliminate the fac-
tors that increase the likelihood of treatment failure. Also, 
according to laboratory studies, it seems not only Vitamin 
D deficiency (VDD) may have an effect in increasing the 
eradication failure rate, but also treatment of such deficien-
cy and supplementation may have direct antimicrobial or 
protective effects on the gastric mucosa against Hp infec-
tion. Therefore, considering the importance of the subject 
matter, the present nested case-control study investigated 
the association of VDD with Hp eradication therapy.
MATERIALS and METHODS
The present study was performed on 200 patients aged 18-
80 years who underwent endoscopy at Loghman Hospital 
from June to March 2019, and the presence of Hp infection 
was confirmed based on histopathological samples. Patients 
with previous history of Hp eradication, renal and hepat-
ic failure, systemic inflammatory or autoimmune disease, 
and history of antibiotic use, vitamin D supplementation, 
antacid or anti-inflammatory drug, and corticosteroid / im-
munosuppressive therapy in the previous two months have 
been excluded from the study. Prior to treatment, serum vi-
tamin D levels were determined in all patients, and they 
were divided into four categories, including vitamin D<10, 
10-20, 21-30, and > 30 ng /dL. All patients underwent four-
week bismuth-based quadruple Hp eradication treatment 
(two amoxicillin 500 mg b.d, two metronidazole 250 mg 
b.d, two bismuth250 mg b.d, and pantoprazole 40 mg b.d.) 
To confirm the eradication of HP, the urea breath test was 
performed for all patients for four weeks after the treat-
ment. Accordingly, patients were divided into two groups: 
failed treatment and successful treatment, and vitamin D 
levels were compared between two groups. All participants 
gave informed written consent prior to the study. All the 
Vitamin D Deficiency and Helicobacter pylori Eradication Rate
Table 1. Distribution of two groups with and without treatment failure 
based on body mass index.(BMI= Body Mass Index)





18.5< (Underweight) 16(34.0) 47(30.7)
0.6
18.5-25 (Normal) 17(36.2) 55(35.9)
25-30 (Overweight) 13(27.7) 39(25.5)
30≤ (Obese) 1(2.1) 12(7.8)
Table 2. Distribution of two groups with and without treatment failure 
based on vitamin D levels.





<10 ng/dL 8 (17.0) 6 (3.9)
<0.001
10-20 ng/dL 19 (40.4) 15 (9.8)
21-30 ng/dL 4 (8.5) 4 (2.6)
30 ng/dL < 16 (34.0) 128 (83.7)
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At the beginning of the treatment, vitamin D levels in the 
majority of patients (40.4%) of the treatment failure group 
was 10-20 ng/dL, but it was more than 30ng/dL in the ma-
jority of patients (83.7%) of the group with optimal thera-
peutic response. Such a difference was statistically signifi-
cant (P < 0.001) (Table 2).
DISCUSSION
CConsidering the high prevalence of H. pylori infection 
(HP) and the importance of its eradication, it is important 
to eliminate the factors that increase the likelihood of treat-
ment failure. Laboratory studies suggest the role of vita-
min D in host immunity against Hp infection as well as 
the specific antibacterial effects of this vitamin against Hp 
pathogen. Therefore, the present study investigated the ef-
fect of VDD on the success rate of eradication treatment 
in Hp-positive patients. The results showed that vitamin D 
level was 10-20 ng/dL in the majority of patients (40.4%) 
in the treatment failure group at the beginning of treatment, 
but it was more than 30 ng/dL  in the majority of patients 
(83.7%) in the group with optimal therapeutic response at 
the beginning of treatment, which was statistically differ-
ent.
A retrospective study (2018) was carried out on 160 pa-
tients with type 2 diabetes who underwent Hp eradication 
treatment from 2015 to 2017 and had their baseline vitamin 
D levels checked. Patients were divided into two groups: 
successful eradication therapy (n=124 people) and failed 
eradication treatment (n=36 people). The statistical analy-
sis showed that the mean vitamin D level in the treatment 
failure group was significantly lower than the successful 
eradication group, which is consistent with the results of 
the present research [16].
A study was carried out on 220 patients diagnosed with Hp 
gastritis using endoscopic biopsy in 2017, and vitamin D 
levels were measured in all of them before the eradication 
treatment. Patients were treated with bismuth-based qua-
druple Hp eradication treatment for 14 days and were then 
divided into two groups based on vitamin D levels: vitamin 
D <10 ng / dL and vitamin D ≥ 10 ng / dL. Hp eradica-
tion was successful in 77.2% of cases. VDD was prevalent 
among 30.5% of the studied population. The mean vitamin 
D levels in the eradication failure group were significantly 
lower. Also, the number of patients with VDD in the treat-
ment failure group was significantly higher than the suc-
cessful treatment group, and the results of the mentioned 
study, similar to the present research, showed that VDD is 
a risk factor for the failure of Hp eradication therapy [15].
A case-control study (2018) was carried out on 150 patients 
diagnosed with Hp gastritis using endoscopy and confirmed 
by stool antigen tests (SATs). Patients were divided into two 
groups based on their vitamin D levels: <20 ng/dL (VDD) 
and ≥ 20 ng/dL. Results showed that vitamin D levels in the 
treatment failure group were significantly lower than in the 
successful treatment group. Besides, the number of patients 
with VDD was significantly higher in the treatment failure 
group, which is consistent with the results of the present 
research [17].
A cross-sectional study (2018) was conducted on 254 pa-
tients aged above 65 years who underwent endoscopy be-
tween the years 2010 and 2017 and were examined for Hp 
infection. Of the total patients, 23 were Hp-positive and 211 
were Hp-negative. Most patients with VDD were in Hp-pos-
itive group. Also, multivariate regression analysis showed 
that VDD was significantly associated with an increased risk 
of Hp infection after the removal of age, sex, variables and 
Charlson comorbidity index (CCI). This suggests that VDD 
has an effect on increasing both the risk of Hp infection and 
treatment failure [18].
In a study in 2012, the mean vitamin D level in 36384 outpa-
tients was measured and determined, and the results of statis-
tical analysis showed the role of hypovitaminosis D (VDD) 
as a risk factor for autoimmune diseases. It was also found 
that lower vitamin D levels in Hp patients can be influential 
factors for more severe invasion of gastric mucosa, which 
can be the main justification for the results obtained in the 
present study [20]. 
In a cross-sectional study on 208 patients with upper gas-
trointestinal symptoms in 2018, they were genotyped for 
VDR polymorphism and the results were compared between 
Hp-positive and Hp-negative individuals. Results showed a 
significant relationship between VDR gene polymorphism 
and Hp infection, which justifies our research findings at the 
molecular level [22].
A case-control study (2014) investigated the role of VDR 
in intrinsic immunity against Hp infection. A total of 17 
Hp-positive patients and 16 controls were included in the 
study, and the results showed overexpression of VDR and 
Cyclic Adenosine Monophosphate in the gastric mucosa in 
cases of Hp infection. The results also showed that VDR 
plays an important role in the gastric mucosal hemostasis 
and protection against Hp infection, which is consistent with 
the findings of the present research [23].
A laboratory study in 2015 showed that the combination 
of vitamin D decomposition products had antibacterial ef-
fects only against Hp, but not other bacteria. Therefore, 
the results of the present research cannot be generalized 
to other bacteria. A laboratory study in 2018 showed that 
some compounds derived from vitamin D, including VDP1 
[(1R,3aR,7aR)-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-
methyl-4H-inden-4-one], have completely specific and very 
strong antibacterial effects against Hp and they can be used 
to produce medicine against this bacterium in the future, and 
the results of the present research also support this theory 
[24].
CONCLUSION
Overall, the results of the present case-control study revealed 
a significant statistical relationship between serum vitamin 
D deficiency level and H. pylori eradication rate. Vitamin D 
deficiency increases H. pylori treatment failure, so measur-
ing serum vitamin D levels in cases of treatment failure and 
the use of vitamin D supplements are recommended in peo-
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ple with vitamin D deficiency to improve the eradication 
treatments of H. pylori.
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